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Abstract
Background: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare acquired inflammatory skeletal disorder of
unknown origin. CRMO was first described by Gideon in 1972 and mainly affects children and young adults
of female gender. The CRMO is part of the clinical picture of non-bacterial Osteomyelitis (NBO) and typically
presents a relapsing recurring course with both remission and spontaneous exacerbation. CRMO is typically
encountered in the limbs and the metaphysis of long bones in particular. Usually the clinical symptoms include
painful swellings of the affected regions. This case report describes the rare case of a CRMO of the mandible
in association with pyoderma gangraenosum.
Case presentation: A 14-year old female caucasian patient, residing in the south of Germany, presented in
the oncological outpatient clinic of our Department of Paediatrics and Adolescent Medicine in June 2014
complaining of increasing neck pain and progressive swelling at her left cheek ongoing for about 6 weeks.
These symptoms had been occurring quarterly for 4 years, but had never been as pronounced. Blood biochemistry
showed a moderately elevated CRP (35 mg/l) and a significantly increased blood sedimentation rate (BSR 48/120 mm).
The panoramic radiograph, however, revealed a bone alteration in the left mandibular region. Further investigations
confirmed the diagnosis of CRMO.
Conclusion: The present case underlines the fact that rare diseases might occasionally present with even more rare
symptoms. These occasions can obviously be considered to present a considerable diagnostic challenge.
Keywords: Chronic recurrent multifocal osteomyelitis, CRMO, Non-bacterial osteomyelitis, NBO, Pyoderma gangraenosum
Abbreviations: BSR/ESR, Blood sedimentation rate; CMFS, Cranio-maxillo-facial surgeon; CRMO, Chronic recurrent
multifocal osteomyelitis; CRP, C-reactive protein; CT, Computed tomography; ENT, Ear nose throat specialist; FD, Fibrous
dysplasia; IBD, Chronic inflammatory bowel disease; LCH, Langerhans cell histiocytosis; MR(I), Magnetic resonance imaging;
NBO, Non-bacterial osteomyelitis; PG, Pyoderma gangraenosum; PR, Panoramic radiograph; SAPHO, Synovitis, acne,
pustulosis, hyperostosis and osteitis
Background
Chronic recurrent multifocal osteomyelitis (CRMO) is a
rare acquired inflammatory skeletal disorder of unknown
origin. CRMO was first described by Gideon in 1972 [1]
and mainly affects children and young adults of female gen-
der [2–4]. Very similar to CRMO is the SAPHO-Syndrome,
whose hallmarks are the presence of synovitis, acne, pustu-
losis, hyperostosis and osteitis (SAPHO). SAPHO-
Syndrome is considered to affect predominantly the adult
population. The age of the patient is, however, not diaforo-
diagnostic [5], since adults with CRMO and children with
SAPHO-Syndrome have been described so far [6, 7].
The CRMO is part of the clinical picture of non-bacterial
Osteomyelitis (NBO) and typically presents a relapsing recur-
ring course with both remission and spontaneous exacerba-
tion. CRMO is typically encountered in the limbs and the
metaphysis of long bones in particular. Usually the clinical
symptoms include painful swellings of the affected regions.
This case report describes the rare case of a CRMO of the
mandible in association with pyoderma gangraenosum.
* Correspondence: Matthias.Wurm@uk-erlangen.de
1Department of Oral and Maxillofacial Surgery, University of
Erlangen-Nürnberg, Glückstrasse 11, 91054 Erlangen, Germany
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wurm et al. BMC Oral Health  (2016) 16:85 
DOI 10.1186/s12903-016-0275-z
Case presentation
A written consent for this case report has been obtained
by the parents. A 14-year old female caucasian patient,
presented in the oncological outpatient clinic of our
Department of Paediatrics and Adolescent Medicine in
June 2014 complaining of increasing neck pain and pro-
gressive swelling at her left cheek about 6 weeks ago
(Fig. 1a). These symptoms had been occurring quarterly
for 4 years, but had never been as pronounced. In all
previous occasions the symptoms had improved with the
use of ibuprofen. Furthermore skin lesions were noticed
on both lower legs. The patient told us that these lesions
had persisted for 3 years and had usually improved dur-
ing the summer (Fig. 1b).
Suffering from ongoing trismus, the patient consulted
an ear nose throat (ENT) specialist 4 months ago. The ini-
tial work diagnosis was that of a parotitis and an antibiotic
therapy was implemented. Due to the persistence of the
symptoms the advice of a cranio-maxillo-facial surgeon
(CMFS) was sought, so as to investigate a possible re-
lation of the symptoms to the wisdom teeth. Pericor-
onitis or any other disease related to wisdom teeth
could indeed be excluded with the help of clinical
examination and radiological investigation (PR - pano-
ramic radiograph).
The PR, however, revealed an alteration of the trabecu-
lar structure of the left mandibular angle (Fig. 2). A Mag-
netic Resonance Imaging (MR) was performed for further
investigation. Suspicion for Langerhans Cell histiocytosis
(LCH), Ewing sarcoma, fibrous dysplasia, lymphoma and
osteomyelitis was risen (Fig. 3). The young patient was
referred to our department of paediatric oncology.
An initial assessment of the patient revealed a good
general but a deteriorated nutritional status. The skin of
the lower legs showed multiple ulcerous blueish skin le-
sions (Fig. 1b) and the skin of the face and the upper
part of the body presented several acne scars. A 7x5cm,
hardened, tender on palpation mass was detected at her
left cheek. No clear local signs of inflammation were
present. The lymph node status was unremarkable.
Further clinical examination revealed an abnormal pos-
ture, characterized by inclination of the head to the left,
elevated shoulders and scoliosis. Pain was elicited on per-
cussion of the cervical spine. Blood biochemistry showed
a moderately elevated CRP (35 mg/l) and a significantly
increased blood sedimentation rate (BSR 48/120 mm).
Ultrasound of the head and neck showed submandibu-
lar cervical lymphadenopathy at the left side and a diffuse
swelling affecting the soft tissues of the left cheek (Fig. 4).
On chest x-ray (pa), no suspicious pulmonary nodules
or consolidations were found.
Further imaging with contrast-enhanced CT was per-
formed which revealed an extensive thickened left corpus
and ramus of the mandible with a soft tissue mass (Fig. 5a).
Destruction of the cortex of the mandible and a massive
periosteal reaction (Fig. 5b), a left-sided cervical lymph-
adenopathy and diffuse contrast-enhancement in the soft
tissue surrounding the mandible were identified. Similar
osseous and soft tissue lesions were detected in the cer-
vical vertebrae 2–5 including the vertebral arches and the
transverse processes.
Biopsies were taken from both the lower jaw and the
skin lesions. The histological examination of the speci-
men from the lower jaw showed features of a benign
Fig. 1 a Distinct swelling of the left cheek (circle). b Skin lesions on both lower limbs (circles)
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fibro-osseous lesion, consistent with fibrous dysplasia or
secondary changes after osteomyelitis (Fig. 6). GNAS
mutational analysis was performed to definetly exclude
FD. The dermatopathological examination showed an
abscess-forming neutrophil inflammation; taking into
consideration the clinical appearance, the findings were
consistent with pyoderma gangraenosum (PG).
Treatment with Ibuprofen and Sulbactam/Amoxicillin
led to significant decrease of the mandibular swelling.
Furthermore the pain in the mandible and the back sub-
sided, resulting in regular posture. An obvious reduction
of the lower limb skin lesions and of acne vulgaris as
well as increasing appetite were observed (Fig. 7).
After taking into consideration the clinical findings, the
results of the performed investigation and the response to
the provided treatment, the diagnosis of a chronic recur-
rent multifocal osteomyelitis (CRMO) was made.
The CRMO is part of the clinical picture of non-
bacterial Osteomyelitis (NBO) which can be classified into
three progression forms - acute NBO, persistent chronic
NBO or chronic recurrent multifocal osteomyelitis [8].
CRMO typically presents a relapsing recurring course
Fig. 2 Alteration of the trabecular structure of the left mandibular angle (circle)
Fig. 3 MRI-T2: Soft-tissue tumour with infiltration of the surrounding bone located at the left corpus and ramus of the lower jar (a, b, c - circles).
Similar osseous and soft tissue lesions were detected in the cervical vertebrae 2–5 (d) (circle) including the vertebral arches and the transverse processes
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with both remission and spontaneous exacerbation [9, 10].
Intermission could last from months to years [11].
Jansson proposed major and minor diagnostic criteria
of NBO (Table 1) [8]. NBO is quite likely if two major or
one major and three minor criteria are met. Jannson also
showed that the fewer criteria are met the more likely is
an acute NBO. Furthermore the more criteria are met
the more likely is a CRMO.
CRMO is a diagnosis that is made by exclusion. Medical
history, radiological diagnostics and a bone biopsy are the
cornerstones for establishing the diagnosis of CRMO. Ac-
cording to the current AWMF-guideline [12] numerous
diagnostic methods might be used to exclude malignant or
inflammatory conditions. The exclusion of malignant pro-
cesses has the highest priority.
CRMO is typically encountered in the limbs and the
metaphysis of long bones in particular. Usually the clin-
ical symptoms include painful swellings of the affected
regions. None of the typically affected sites were in-
volved in our patient; two rare sites – the lower jaw and
vertebral bodies – were affected instead. Radiological
signs are hyperostosis and osteitis with lightening of the
affected areas and surrounding sclerosis. As in children
multifocal bone lesions could be consistent with a good
Fig. 4 Ultrasound of the soft tissue of the cheeks (a, b). Inhomogenous widening on the left side (b) (circle)
Fig. 5 a, c The CT reveals an extensive thickening of the left mandible with contrast agent enhancing soft tissue mass (circles). b, d Destruction of
the cortex of the mandible and massive periostal reaction. Similar changes can also be found in the posterior aspect of the cervical spine (circles)
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number of differential diagnoses–e.g. Langerhans cell
histiocytosis or leukemia [13], a biopsy is recommended
[14]. Ewing sarcoma could not radiologically be excluded
since it might look identically. An exclusion of this diag-
nosis could only be achieved through the following biopsy.
Histologically CRMO shows characteristics of inflamma-
tion and/or fibrosis without a detectable pathogen [13, 14].
In our patient the pattern of a benign fibro-osseous lesion
was present consistent with an expired inflammatory
process. Fibrous dysplasia could be excluded from the
differential diagnosis since a negative GNAS1-mutational
status (GNAS 1 wild type) was identified. The histomor-
phological pattern was consistent with changes after
osteomyelitis or previous surgical procedure. As there were
no earlier interventions CRMO became more likely.
Jansson determined that in 31 % of CRMO patients
exoskeletal findings were present [8]. An association
with autoimmune disorders as IBD (chronic inflamma-
tory bowel disease) [2] respectively Crohn’s disease [15]
or Takayasu arteriitis [16] is described. Far more fre-
quent - incidence varies from 23 to 80 % [7]- associated
skin lesions are present – as in our patient. Not only
psoriasis and palmoplantar pustolosis [13] but also pyo-
derma gangrenosum [2] have been described so far.
However various autoimmune diseases are considered as
associated skin lesions but as they also occur alone, it
can easily happen that these lesions are not included in
the diagnosis -making [17–20]. Our patient also pre-
sented dubious skin lesions consistent with pyoderma
gangraenosum. Dagan et al. wrote a case report of a
CRMO in the ninth and tenth ribs as well as the tibia
with associated PG. Nurre et al. presented a case of
CRMO with associated PG. However CRMO presented
initially at the left hand as well as other bones except the
mandible. After biopsy a PG presented at the site of bi-
opsy. Innis described a similar case with involvement of
several bones. In his case, PG was present at the scalp and
the limbs. In an article of Edwards et al. CRMO mani-
fested at both tibiae and associated PG. To our knowledge
this is the first of such case –involvement of the mandible
with associated PG- described in the literature.
Due to the fact that its pathogenesis remains unclear,
its treatment is mainly symptomatic. Anti-inflammatory
drugs form the basis of the current treatment concept;
occasionally the use of cortisone therapy might be
Fig. 6 Biopsy from the lower jaw: Features of a benign fibro-osseous
lesion, consistent with fibrous dysplasia or secondary changes after
osteomyelitis. HE 100×
Fig. 7 MRI (a) and the patient (b) 6 months after therapy. The MRI shows a distinct decrease of the thickening of the left mandible and the soft
tissue mass in the posterior aspect of the cervical spine (circles)
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necessitated in severe cases [4, 15, 21]. Our patient
showed a good response to anti-inflammatory drugs.
Bisphosphonates like pamidronate showed initial promis-
ing results since they act both as anti-resorptive and anti-
inflammatory agents [22]. TNFα-inhibitors seem to be
effective as well but as Costa-Reis stated there is no consen-
sus about this regime so far [23, 24]. In severe cases limited
surgical interventions or orthopedic procedures might be
helpful or even necessary. Physiotherapeutic treatment
might reduce the symptoms when the spine is affected.
The prognosis is unclear so far. Results from studies
vary from complete remission to symptomatic courses
for as long as 16 years [3, 13].
By reflecting on the NBO criteria and how they applied
in our case it becomes apparent that this rare disease has
in this instance manifested in an even more unusual way.
Involvement of the lower jaw is very rare and accounts for
about 5 % of the cases [7]. Involvement of the spine ac-
counts about 30 % of the cases. Pathological fractures are
described in the literature [8]. Concurrent appearance of
CRMO and pyoderma gangrenosum is mentioned sporad-
ically in the literature so far [2, 16, 25]. The combination
of multifocal bone lesions at atypical sites and PG has ob-
viously encumbered our diagnostic efforts. A biopsy to
confirm or exclude LCH, Ewing sarcoma, fibrous dysplasia
and lymphoma was mandatory. Exclusion of fibrous
dysplasia was supported by GNAS1 mutational analysis
which revealed the presence of the wild type sequence,
rendering this diagnosis unlikely. The signs of fibrosis that
were detected were also consistent with CRMO. Therefore
three of four major criteria were met even though the sites
of the skeleton that were affected were atypical.
The patient’s work-up showed that three minor criteria
were also met: Blood biochemistry revealed a normal
blood count; CRP and ESR were moderately elevated
whilst the patient presented a good general state of
health. Observation time was longer than 6 months.
Corresponding to recent studies the patient showed a
good response to Ibuprofen.
Conclusion
The present case underlines the fact that rare diseases
might occasionally present with even more rare symp-
toms. CRMO in the mandible and CRMO with associ-
ated PG have already been described. For the first time
we described an involvement of the mandible with asso-
ciated PG. These occasions and combinations can obvi-
ously be considered to present a considerable diagnostic
challenge. An in depth knowledge about the disease and
its symptoms is a matter of extreme value in such cases.
In addition, an accurate medical history is of para-
mount importance when uncertain changes of the cra-
nial skeleton are present. The physician should always
enquire about new osseous changes, pain or new lesions
and additional questions e.g. SCHOLAR [26]. If uncer-
tain skin lesions or rheumatic disorders are present,
CRMO should be in mind. NBO criteria might be help-
ful for diagnosis. As there are various manifestations, an
interdisciplinary approach can be useful.
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